ReviewTherapeutics and clinical risk management2026
Exploring the Comprehensive Treatment of Hashimoto's Thyroiditis with Traditional Chinese Medicine from the Perspective of Modern Medicine.
Review in Therapeutics and clinical risk management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hashimoto's thyroiditis (HT) is a common autoimmune disorder characterized by the presence of thyroid-specific autoantibodies and lymphocytic infiltration within the thyroid gland. Although its etiology is multifactorial and complex-encompassing genetic susceptibility, environmental influences, and epigenetic modifications-HT primarily presents as primary hypothyroidism. Conventional management predominantly involves hormone replacement therapy; however, Traditional Chinese Medicine (TCM) has demonstrated promising efficacy and safety in the treatment of HT. This review critically examines the application of TCM in HT management, contextualized within contemporary understandings of the disease's pathophysiology. TCM exerts therapeutic effects through multiple mechanisms, including immunomodulation, attenuation of oxidative stress, and inhibition of thyroid cell apoptosis. Clinical studies indicate that TCM interventions, such as herbal formulations and acupuncture, can effectively enhance thyroid function, decrease autoantibody levels, and improve patients' quality of life. The integration of TCM with standard Western medical treatments offers a valuable complementary strategy for HT, addressing both symptomatic relief and underlying immune dysregulation. Nonetheless, there remains a need for large-scale, multicenter randomized controlled trials to establish standardized treatment protocols and to confirm the long-term safety and efficacy of TCM approaches. Overall, TCM represents a promising adjunctive therapeutic option for HT, expanding the range of treatment modalities beyond conventional hormone replacement. Future investigations should aim to elucidate the molecular mechanisms underlying TCM's effects and to optimize therapeutic regimens to maximize clinical benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.